illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Invitae
Company logo

Invitae | Sustainability Performance

https://www.invitae.com/
Linkedin

Provides genetic testing services with applications in hereditary disease screening, oncology, and reproductive health. Its platforms analyze DNA to deliver clinical insights for patients and healthcare providers. The company emphasizes integration of genetic information into medical decision-making.

2010

United States

1,001 - 5,000 employees

Biotechnology

$500M - 1B in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#9453
Overall
#2118
in United States
#203
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Governance
TargetsESG scores and exclusions
Financial Data
Business performanceCapital & innovation

View similiar companies


Company logo
Envista

United States, Hospital & Health Care, Medical Device


Company logo
Encompass health

United States, Hospital & Health Care, Hospital & Health Care


Company logo
Cigna Healthcare

United States, Hospital & Health Care, Hospital & Health Care

Market cap

0.0 $, 2024

Revenue

516.3M $, 2026

R&D intensity

52.36% 2023

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

0.0 $, 2024▼NaN% YoY

Revenue

516.3M $, FY2026▼NaN% YoY

EBITDA

0.0 $, FY2026▼9.1% YoY

Operating margin

36% Industry: -370▲478.8% YoY

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-546.3M 2022▼12.5% YoY

Capex

53.0M 2022▼1.9% YoY

R&D intensity

52.4%FY2023

R&D as % of revenue

R&D as % of revenue
Industry benchmark

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

44%
Independent Directors

7 out of 16 incl. management

Powered by illuminem

Overall score

58

Environment

46

Social

77

Governance

51

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees


    Available in
    Scale package

    Access
  • Email

  • Email